BOT 4.05% 38.5¢ botanix pharmaceuticals ltd

Sofdra - Post approval royalties, costs and earnings, page-31

  1. 4,201 Posts.
    lightbulb Created with Sketch. 5498
    Yep - You missed something, as did big Pharma.

    Watch the company webinar on youtube after the CRL was issued. It is very clear for investors what happened, and what is about to happen


 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.